- Home
- MOLN vs IDR Comparison
MOLN vs IDR Comparison
Compare MOLN & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- IDR
- Stock Information
- Founded
- MOLN 2004
- IDR 1996
- Country
- MOLN Switzerland
- IDR United States
- Employees
- MOLN N/A
- IDR N/A
- Industry
- MOLN
- IDR Precious Metals
- Sector
- MOLN
- IDR Basic Materials
- Exchange
- MOLN Nasdaq
- IDR Nasdaq
- Market Cap
- MOLN 142.6M
- IDR 378.0M
- IPO Year
- MOLN 2021
- IDR N/A
- Fundamental
- Price
- MOLN $3.70
- IDR $28.96
- Analyst Decision
- MOLN Hold
- IDR Strong Buy
- Analyst Count
- MOLN 1
- IDR 1
- Target Price
- MOLN $4.00
- IDR $17.50
- AVG Volume (30 Days)
- MOLN 5.1K
- IDR 426.7K
- Earning Date
- MOLN 11-05-2025
- IDR 11-03-2025
- Dividend Yield
- MOLN N/A
- IDR N/A
- EPS Growth
- MOLN N/A
- IDR 57.55
- EPS
- MOLN N/A
- IDR 0.64
- Revenue
- MOLN $856,302.00
- IDR $30,496,328.00
- Revenue This Year
- MOLN N/A
- IDR $21.91
- Revenue Next Year
- MOLN $1,000.00
- IDR $5.47
- P/E Ratio
- MOLN N/A
- IDR $45.25
- Revenue Growth
- MOLN N/A
- IDR 59.64
- 52 Week Low
- MOLN $3.36
- IDR $9.67
- 52 Week High
- MOLN $7.60
- IDR $32.01
- Technical
- Relative Strength Index (RSI)
- MOLN 50.41
- IDR 59.47
- Support Level
- MOLN $3.69
- IDR $27.85
- Resistance Level
- MOLN $3.79
- IDR $32.01
- Average True Range (ATR)
- MOLN 0.10
- IDR 2.00
- MACD
- MOLN -0.00
- IDR -0.23
- Stochastic Oscillator
- MOLN 43.24
- IDR 42.92
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.